| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neurocrine Biosciences, Inc. (NBIX) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 32 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 140.4K | $22.67M | - | |
| Other | 52.8K | $8.52M | - | |
| Other | 46.8K | $7.55M | - | |
| Other | 39.6K | $6.40M | -36,937 | |
| Other | 36.8K | $5.95M | -22,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 8, 2022 | Gano Kyle54 | Chief Business Development Off | Sell | 6,880 | $80.61 | $554,627.74 | -1.3% | -5.2% | +30.7% | |
| Feb 8, 2022 | Lloyd-Smith Malcolm49 | Chief Regulatory Officer | Sell | 3,382 | $80.48 | $272,167.90 | -4.6% | -5.2% | +30.7% | |
| Feb 8, 2022 | Gorman Kevin Charles55 | Chief Executive Officer | Sell | 10,984 | $80.54 | $884,674.32 | -0.6% | -5.2% | +30.7% | |
| Feb 8, 2022 | Boyer David W.51 | Chief Corp. Affairs Officer | Sell | 940 | $79.99 | $75,192.83 | -15.3% | -5.2% | +30.7% | |
| Feb 8, 2022 | Lippoldt Darin60 | Chief Legal Officer | Sell | 4,079 | $80.45 | $328,159.81 | -2.7% | -5.2% | +30.7% | |
| Feb 8, 2022 | Cooke Julie59 | Chief Human Resources Officer | Sell | 2,858 | $80.38 | $229,727.32 | -4.2% | -5.2% | +30.7% | |
| Feb 8, 2022 | Benevich Eric62 | Chief Commercial Officer | Sell | 5,099 | $80.57 | $410,820.89 | -6.4% | -5.2% | +30.7% | |
| Feb 8, 2022 | Abernethy Matt57 | Chief Financial Officer | Sell | 4,290 | $80.53 | $345,485.80 | -6.9% | -5.2% | +30.7% | |
| Jan 24, 2022 | Sherwin Stephen A | Director | Sale+OE | 15,000 | $74.43 | $1,116,378.00 | -37.4% | +23.6% | +43.2% | |
| Jan 10, 2022 | Roberts Eiry49 | Chief Medical Officer | Sell | 2,632 | $74.50 | $196,087.68 | -11.0% | +28.8% | +43.6% |